Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

TG Therapeutics Inc (NASDAQ:TGTX)

11.75
Delayed Data
As of Aug 23
 +0.25 / +2.17%
Today’s Change
4.10
Today|||52-Week Range
15.35
+152.69%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2013

2014

2015

2016
Revenue and IncomeNet Revenues152.4K152.4K152.4K152.4K
 
 
 
 
 
Depreciation And Amortization1.1K3.9K15.5K63.0K
 
 
 
 
 
 
Operating ExpensesGross Income----------
General Expenses20.3M55.9M63.3M79.1M
 
 
 
 
 
Research And Development13.7M40.1M47.7M69.2M
 
 
 
 
 
Total Operating Expenses20.3M55.9M63.3M79.1M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-20.2M-55.7M-63.2M-79.0M
 
 
 
 
 
Extraordinary Credit3.3M720.0K1.0M995.7K
 
 
 
 
 
Extraordinary Charge-2.8M0.000.000.00
 
 
Interest Expense On Debt952.9K930.7K972.7K886.1K
 
 
 
 
 
Other Expenses108.9K95.4K0.00283.5K
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-20.5M-55.8M-62.9M-78.3M
 
 
 
 
 
Net Income-20.5M-55.8M-62.9M-78.3M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS25.4M34.1M45.6M49.0M
 
 
 
 
 
Shares To Calculate EPS Diluted25.4M34.1M45.6M49.0M
 
 
 
 
 
 
Earnings Per ShareEPS-$0.81-$1.64-$1.38-$1.60
 
 
 
 
 
EPS Diluted-$0.81-$1.64-$1.38-$1.60